
Sign up to save your podcasts
Or


Plus: U.S. regulators are investigating several big banks over how they respond when customers dispute transactions on the payment platform Zelle. Novo Nordisk said quarterly sales of its weight-loss drug Wegovy missed expectations. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.2
652652 ratings
Plus: U.S. regulators are investigating several big banks over how they respond when customers dispute transactions on the payment platform Zelle. Novo Nordisk said quarterly sales of its weight-loss drug Wegovy missed expectations. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,851 Listeners

1,713 Listeners

4,420 Listeners

406 Listeners

427 Listeners

1,649 Listeners

1,448 Listeners

1,044 Listeners

1,320 Listeners

6,097 Listeners

1,573 Listeners

212 Listeners

1,322 Listeners

586 Listeners

151 Listeners

87 Listeners

80 Listeners

150 Listeners